Brenntag (BNR) Given a €50.00 Price Target at Baader Bank

Brenntag (FRA:BNR) has been assigned a €50.00 ($58.14) price objective by equities researchers at Baader Bank in a research note issued to investors on Thursday, Borsen Zeitung reports. The firm currently has a “buy” rating on the stock. Baader Bank’s price objective suggests a potential upside of 5.78% from the company’s previous close.

A number of other equities research analysts have also recently weighed in on BNR. Kepler Capital Markets set a €56.00 ($65.12) price objective on Brenntag and gave the company a “buy” rating in a research note on Thursday, April 4th. Jefferies Financial Group set a €42.00 ($48.84) price objective on Brenntag and gave the company a “neutral” rating in a research note on Thursday, December 27th. JPMorgan Chase & Co. set a €50.00 ($58.14) price objective on Brenntag and gave the company a “buy” rating in a research note on Thursday, January 10th. UBS Group set a €55.00 ($63.95) price objective on Brenntag and gave the company a “buy” rating in a research note on Monday, January 7th. Finally, Credit Suisse Group set a €52.00 ($60.47) price objective on Brenntag and gave the company a “buy” rating in a research note on Tuesday, February 26th. Five investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Brenntag presently has an average rating of “Buy” and a consensus target price of €53.46 ($62.16).

Shares of FRA BNR opened at €47.27 ($54.97) on Thursday. Brenntag has a twelve month low of €43.06 ($50.07) and a twelve month high of €56.25 ($65.41).

About Brenntag

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

See Also: The Role of a Fiduciary and Individual Investors

Analyst Recommendations for Brenntag (FRA:BNR)

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.